证券日报网讯 12月15日晚间，晨丰科技发布公告称，公司、保荐人长江证券承销保荐有限公司与开户 行浙商银行股份有限公司北京分行签署了《募集资金专户存储三方监管协议》，对募集资金采取专户存 储管理。 （编辑 任世碧） ...

证券代码：603685 证券简称：晨丰科技 公告编号：2025-122 浙江晨丰科技股份有限公司 关于签订募集资金专户存储三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江晨丰科技股份有限公司向特 定对象发行股票注册的批复》（证监许可﹝2025﹞722 号），浙江晨丰科技股份 有限公司（以下简称"公司"）向特定对象发行人民币普通股（A 股）股票 49,484,821 股，发行价格为 8.68 元/股，募集资金总额为人民币 429,528,246.28 元，扣除相关发行费用后实际募集资金净额为人民币 418,905,189.67 元。上述 募集资金已于 2025 年 12 月 4 日到位，天健会计师事务所（特殊普通合伙）对 本次募集资金到账情况进行了审验，并出具了《验资报告》（天健验﹝2025﹞426 号）。 二、《募集资金专户存储三方监管协议》的签订情况和募集资金专户的开立 情况 为规范公司募集资金的管理和使用，保护投资者的合法权益，根据《上市 公 ...

Group 1 - Anbotong plans to issue H-shares and list on the Hong Kong Stock Exchange, with the board authorizing management to start preparations within 12 months [1] - Xiangsheng Medical proposes a cash dividend of 3 yuan per 10 shares for the first three quarters of 2025 [2] - Junshi Biosciences receives FDA approval for clinical trials of JS212, a dual-specific antibody-drug conjugate for treating advanced solid tumors [3] Group 2 - Zhonghuan Environmental plans to raise up to 300 million yuan by issuing shares to a specific entity, with funds allocated for working capital and bank loan repayment [4] - Guao Technology announces a change in actual control to Xu Yinghui, with stock resuming trading on December 15 [5] - Jiaze New Energy intends to invest approximately 3.557 billion yuan in a green hydrogen and methanol project in Heilongjiang [6] Group 3 - Shanghai Airport reports a 15.47% year-on-year increase in passenger throughput at Pudong International Airport for November [7] - Innovent Biologics achieves primary endpoint in a Phase IIb study of Obinutuzumab for systemic lupus erythematosus, with plans for a Phase III trial [8] - Saiyi Information leads a national major science and technology project on intelligent manufacturing systems and robotics [9] Group 4 - Yipin Hong's Qinxing Qingjie oral solution is approved as a national second-level protected traditional Chinese medicine [10] - Yipin Hong's stake in US-based Arthrosi Therapeutics is set to be acquired by Sobi for a total of up to 950 million USD [11] - Pudong Jinqiao announces the resignation of Chairman Wang Ying due to job transfer [12] Group 5 - Jiaze New Energy plans to invest in two wind power projects with a total estimated investment of approximately 2.366 billion yuan [13] - Jinpan Technology receives approval from the CSRC for issuing convertible bonds to unspecified investors [14] - Zoli Pharmaceutical intends to acquire a multi-trace element injection asset group for 356 million yuan [15] Group 6 - Jiuan Medical's US subsidiary receives pre-market notification from the FDA for multiple testing products [16][17] - Changfei Optical Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [18] - Chenfeng Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [19][20][21][22]

12月14日，截至20时，上市公司发布的股份减持公告汇总如下： 晨丰科技（603685）股东杭州宏沃计划在2026年1月7日至4月6日期间，通过集中竞价和大宗交易方式合 计减持不超过752万股，约占公司总股本的3%。 新雷能（300593）董事、副总经理刘志宇因资金需求，计划自2026年1月7日至2026年4月6日期间通过集 中竞价和大宗交易方式减持不超过40万股公司股份，占剔除回购专用账户后的总股本的0.07%。 凯普生物（300639）职工代表董事谢龙旭因个人资金需求，计划在2026年1月7日至2026年4月6日期间， 通过集中竞价方式减持不超过9.39万股公司股份，约占公司总股本的0.0150%。 百诚医药（301096）股东富诚海富资管—杭州银行—富诚海富通百诚医药员工参与创业板战略配售资管 计划，计划在未来三个月内通过大宗交易或集中竞价方式减持不超过55万股，约占公司总股本的 0.5077%。 万丰股份（603172）股东舟山瑞好通过大宗交易方式减持公司股份233万股，占公司总股本的1.75%。 圣诺生物（688117）股东川发投资通过集中竞价及大宗交易方式累计减持公司股份403万股，占公司总 股本 ...

（编辑 王江浩） 证券日报网讯 12月14日晚间，晨丰科技公告称，持股4.3134%的股东杭州宏沃计划自2026年1月7日至4 月6日，通过集中竞价减持不超2509505股（占总股本1%）、大宗交易减持不超5019011股（占总股本 2%），减持价格按市场价确定。 ...

Corporate Changes - Wang Ying, the chairman of Pudong Jinqiao, has resigned due to work transfer [2] - Xu Yinghui has become the new actual controller of Gu Ao Technology after a voting rights entrustment agreement [4][5] Profit Distribution - Xiangsheng Medical plans to distribute a cash dividend of 3 yuan per 10 shares for the first three quarters of 2025 [3] Investment Projects - Jiaze New Energy intends to invest approximately 3.557 billion yuan in a green hydrogen and methanol co-production project in Jixi City, Heilongjiang Province [6] - Longfei Optical Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [11] Financing Activities - Jinpan Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [7] Acquisitions - Zoli Pharmaceutical has signed an agreement to acquire a multi-trace element injection asset group from Future Medicine for a total price of 356 million yuan [8] Product Approvals - Nine安 Medical's U.S. subsidiary has received pre-market notifications from the FDA for its multi-detection kits for various viruses [9] National Projects - Saiyi Information has been approved to lead a national major science and technology project focused on intelligent manufacturing systems and robotics [10]

Group 1 - Pudong Jinqiao's chairman Wang Ying has resigned due to job transfer, ceasing to hold positions as director, chairman, and committee member [2] - Xiangsheng Medical plans to distribute a cash dividend of 3 yuan per 10 shares to all shareholders based on the total share capital [3] - Gu Ao Technology's actual controller has changed to Xu Yinghui, with stock resuming trading on December 15 [4] Group 2 - Jiaze New Energy plans to invest approximately 3.557 billion yuan in a green hydrogen and aviation fuel chemical co-production project in Jixi City [5] - Jinpan Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [6] - Zoli Pharmaceutical intends to acquire a multi-trace element injection asset group for a total price of 356 million yuan [7] Group 3 - Jiuan Medical's U.S. subsidiary has received pre-market notifications from the FDA for four and three-in-one testing products [8] - Saiyi Information has been approved for a national major science and technology project focusing on intelligent manufacturing systems and robotics [9] - Changfei Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [10] Group 4 - Chengfeng Technology's shareholder, Hangzhou Hongwo, plans to reduce its stake by up to 3% of the company's shares [12] - Minxin Co., Ltd.'s deputy general manager plans to reduce holdings by up to 220,000 shares, representing 0.3925% of the total share capital [13] - Xinle Energy's director plans to reduce holdings by up to 400,000 shares, accounting for 0.07% of the total share capital [14]

格隆汇12月14日丨晨丰科技(603685.SH)发布股东减持股份计划公告，本公告发布之日起15个交易日后3 个月内，杭州宏沃自有资金投资有限公司(以下简称"杭州宏沃")拟通过集中竞价交易方式减持公司股份 不超过250.95万股，即不超过公司股份总数的1%；通过大宗交易方式减持公司股份不超过501.90万股， 即不超过公司股份总数的2%。减持价格根据市场价格确定。 ...

每经AI快讯，晨丰科技（SH 603685，收盘价：19.74元）12月14日晚间发布公告称，截至本公告披露 日，杭州宏沃自有资金投资有限公司持有浙江晨丰科技股份有限公司股份约1082万股，占公司总股本的 约4.31%。本公告发布之日起15个交易日后3个月内，通过集中竞价交易方式减持公司股份不超过约251 万股，即不超过公司股份总数的1%；通过大宗交易方式减持公司股份不超过约502万股，即不超过公司 股份总数的2%。减持价格根据市场价格确定。若减持期间公司有减资、送红股、资本公积转增股本、 增发新股或配股等除权除息事项，相关减持股份数量将进行相应调整。 2024年1至12月份，晨丰科技的营业收入构成为：电气机械及器材制造行业占比81.08%，电力和热力生 产和供应业占比13.07%，其他业务占比5.86%。 截至发稿，晨丰科技市值为50亿元。 每经头条（nbdtoutiao）——美股AI突变！OpenAI沦为"股价毒药"，硅谷八巨头一夜蒸发3.8万亿元市 值，专家：看好谷歌，其拥有两项致胜"法宝" （记者 曾健辉） ...

证券代码：603685 证券简称：晨丰科技 公告编号：2025-121 浙江晨丰科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 股东名称 | 杭州宏沃自有资金投资有限公司 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | | | 直接持股 5%以上股东 | □是 | √否 | | | 董事、监事和高级管理人员 | □是 | √否 | | | 其他：持股 5%以下股东 | | | | 持股数量 | 10,824,600股 | | | | 持股比例 | 4.3134% | | | | 当前持股股份来源 | IPO 前取得：6,304,700股 | | | | 一、减持主体的基本情况 | | --- | 1 二、减持计划的主要内容 股东持股的基本情况：截至本公告披露日，杭州宏沃自有资金投资有 限公司（以下简称"杭州宏沃"或"本企业"）持有浙江晨丰科技股份 有限公司（以下简称"公司 ...